[Cardiotoxicity of n-methyl-glucamine antimoniate (Glucantime). A case report]
- PMID: 18054189
- DOI: 10.1016/j.medmal.2007.08.001
[Cardiotoxicity of n-methyl-glucamine antimoniate (Glucantime). A case report]
Abstract
The pentavalent antimonial meglumine (Glucantime) is the drug of choice in treatment of cutaneous leishmaniasis in Tunisia. It may create severe adverse effects. A ten year-old girl was treated by Glucantime for cutaneous leishmaniasis. On the eighth day of treatment, she developed palpitations and precordialgia. The ECG showed T wave inversion prolongation of corrected QT interval. Drug therapy was stopped. Within a few days, she recovered and her elctrocardiographic changes came back to normal. The cardio toxicity of Glucantime may be severe. Electrocardiographic changes are the primary signs. Long term ECG follow-up is necessary.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical